HSBC Holdings’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

HSBC Holdings’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-18,500	Closed	-$1.15M	–	2195
2015 Q2	$1.15M	Buy	+18,500	New	+$1.15M	﹤0.01%	1207
2015 Q1	–	Sell	-10,000	Closed	-$540K	–	2138
2014 Q4	$540K	Hold	10,000	–	–	﹤0.01%	1470
2014 Q3	$530K	Buy	+10,000	New	+$508K	﹤0.01%	1455
2013 Q3	–	Sell	-6,800	Closed	-$240K	–	1791
2013 Q2	$240K	Buy	+6,800	New	+$230K	﹤0.01%	1396

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Hoxton Financial Shepherdstown, West Virginia $194M AUM 6.21% 1-Year Est. Return

HSBC Holdings's XPH Position: Q3 2015 in Review

HSBC Holdings sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2015, closing a stake of 18,500 shares — an estimated $1.15M sold.

HSBC Holdings first reported a position in XPH in Q2 2013 and held it in 4 quarters. The position peaked at $1.15M in Q2 2015. 77 funds tracked by Wall St. Rank hold XPH as of Q3 2015.

HSBC Holdings reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
HSBC Holdings sold 18,500 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2015, an estimated $1.15M.
HSBC Holdings first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and held it in 4 quarters.
HSBC Holdings's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.15M in Q2 2015.
77 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2015.

Based on HSBC Holdings's 13F filing for Q3 2015, filed 12 Nov 2015.